B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 40,857 shares of the company's stock, valued at approximately $1,979,000. B. Metzler seel. Sohn & Co. Holding AG owned about 0.08% of Azenta at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Redwood Investment Management LLC bought a new position in Azenta in the first quarter valued at about $1,497,000. Wesbanco Bank Inc. increased its position in Azenta by 72.2% during the 3rd quarter. Wesbanco Bank Inc. now owns 31,000 shares of the company's stock valued at $1,502,000 after purchasing an additional 13,000 shares during the period. American Century Companies Inc. raised its holdings in Azenta by 66.3% during the 2nd quarter. American Century Companies Inc. now owns 69,955 shares of the company's stock worth $3,681,000 after purchasing an additional 27,882 shares during the last quarter. Royce & Associates LP lifted its position in shares of Azenta by 7.8% in the 3rd quarter. Royce & Associates LP now owns 739,977 shares of the company's stock worth $35,844,000 after purchasing an additional 53,584 shares during the period. Finally, Sanctuary Advisors LLC acquired a new position in shares of Azenta in the 2nd quarter worth approximately $222,000. 99.08% of the stock is currently owned by institutional investors.
Azenta Price Performance
Shares of NASDAQ:AZTA traded down $0.37 during mid-day trading on Friday, hitting $45.16. The company had a trading volume of 10,015,198 shares, compared to its average volume of 555,711. The company has a market capitalization of $2.21 billion, a PE ratio of -15.21 and a beta of 1.48. Azenta, Inc. has a one year low of $38.82 and a one year high of $69.16. The firm has a fifty day moving average price of $45.22 and a 200 day moving average price of $50.12.
Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.08. The firm had revenue of $170.00 million for the quarter, compared to analyst estimates of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The business's quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.13 earnings per share. Research analysts expect that Azenta, Inc. will post 0.4 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, Director William L. Cornog acquired 12,500 shares of Azenta stock in a transaction on Monday, November 18th. The stock was purchased at an average price of $39.60 per share, with a total value of $495,000.00. Following the completion of the purchase, the director now owns 14,755 shares of the company's stock, valued at approximately $584,298. The trade was a 554.32 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Herman Cueto sold 1,595 shares of the firm's stock in a transaction that occurred on Thursday, October 17th. The shares were sold at an average price of $43.68, for a total value of $69,669.60. Following the completion of the sale, the chief financial officer now directly owns 24,604 shares of the company's stock, valued at $1,074,702.72. This trade represents a 6.09 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 3,018 shares of company stock worth $126,689. Corporate insiders own 1.77% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on AZTA shares. Evercore ISI lowered their target price on shares of Azenta from $53.00 to $50.00 and set an "in-line" rating for the company in a research note on Tuesday, October 1st. Needham & Company LLC lowered their price objective on Azenta from $69.00 to $55.00 and set a "buy" rating for the company in a research report on Wednesday, November 13th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $63.60.
Read Our Latest Stock Analysis on AZTA
Azenta Company Profile
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
See Also
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
